Zenas BioPharma, Inc.

NASDAQ:ZBIO

Biotechnology

Healthcare
$25.04 +3.46%

+$0.64 today

Market cap
$1.70B
Beta
-0.69
P/E (TTM)
-2.5
EPS (TTM)
-$7.64
52W Low $8.91High $44.60

Volume 0.27M

Average 0.71M

Income Statement

Follow revenue through to earnings.

Revenue

$10.00M

FY 2025 · Annual

+100.0% YoY

Operating Income

-$211.38M

FY 2025 · Annual

Net Income

-$377.74M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue050M5M10M
Cost of Revenue61.69M0139.14M0
Gross Profit(61.69M)50M(134.14M)10M
Gross Margin—100.0%-2682.8%100.0%
Research & Development62.69M60.03M139.14M168.06M
Selling, General & Admin13.51M17.11M29.75M53.32M
Operating Expenses14.51M87.15M29.75M221.39M
Depreciation & Amortization78K113K137K56K
EBITDA(75.12M)(27.03M)(156.42M)(370.43M)
EBITDA Margin—-54.1%-3128.4%-3704.3%
Operating Income(76.2M)(37.15M)(163.89M)(211.39M)
Operating Margin—-74.3%-3277.8%-2113.8%
Interest Income00012.15M
Interest Expense0007.33M
Other Income / Expenses(43.08M)324K7.33M(166.43M)
Income Before Tax(119.28M)(36.82M)(156.56M)(377.82M)
Pre-Tax Margin—-73.6%-3131.2%-3778.2%
Income Tax Expense0301K429K(79K)
Net Income(119.28M)(37.12M)(156.99M)(377.74M)
Net Margin—-74.2%-3139.8%-3777.4%
EPS (Basic)(3.11)(0.97)(3.76)(8.44)
EPS (Diluted)(3.11)(0.97)(3.76)(8.44)
Weighted Avg Shares38.32M38.32M41.79M44.73M
Weighted Avg Shares (Diluted)38.32M38.32M41.79M44.73M

ZBIO Earnings Waterfall · TTM

NASDAQ:ZBIO · Revenue to Net Income

Key Ratios

EPS$-9.10
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-2.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$425.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-9.10, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 6, 2026
424B5424B5 filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026

How much revenue does ZBIO generate?

Zenas BioPharma, Inc. (ZBIO) reported $10.00M of revenue in fiscal 2025.

Is ZBIO profitable?

Zenas BioPharma, Inc. (ZBIO) reported -$377.74M of net income, with a net margin of -3777.4%.